Ataxia Telangiectasia (A-T) Trial Launch

March 23, 2022, marks the official launch of the Ataxia Telangiectasia (A-T) trial.

Thank you to the multidisciplinary efforts of Dr David Coman, Professor Martin Lavin and their teams for their tireless pursuit to find a new treatment option for children with A-T.

To the families impacted by this genetic condition and organisations such as BrAshA-T Ataxia-Telangiectasia and Rare Voices Australia – this is for you!

Greg Hunt MP, we are grateful for your heartfelt support and the $2.46 million grant received from the Medical Research Future Fund.

None of this would be possible without all of you.

Find out more about A-T and the ongoing trial: http://ow.ly/JmHA50IpVsG
Or support us by making a donation today: http://ow.ly/fbt950IpVta